PROM1 and glioblastoma: Evidence mounting in support of GBM recurrence and invasive nature are in part due to the presence of CD133+ cancer stem cells (CSC), which display radioresistant, chemoresistant, self-renewal, and tumorigenic potential [49,50,51].